"39822-0205-1" National Drug Code (NDC)

Pancrelipase 1 BOTTLE in 1 CARTON (39822-0205-1) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE
(X-GEN Pharmaceuticals, Inc.)

NDC Code39822-0205-1
Package Description1 BOTTLE in 1 CARTON (39822-0205-1) > 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Product NDC39822-0205
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NamePancrelipase
Non-Proprietary NamePancrelipase
Dosage FormCAPSULE, DELAYED RELEASE
UsageORAL
Start Marketing Date20090922
End Marketing Date20180331
Marketing Category NameNDA AUTHORIZED GENERIC
Application NumberNDA022210
ManufacturerX-GEN Pharmaceuticals, Inc.
Substance NamePANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE
Strength5000; 17000; 27000
Strength Unit[USP'U]/1; [USP'U]/1; [USP'U]/1

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/39822-0205-1